DMCC Speciality Chem

₹318.8 12.2 | 4%

WEBSITE BSE:506405 NSE : DMCC 10 May, 16:01

Market Cap ₹795 Cr.

Stock P/E 63.6

P/B 3.9

Current Price ₹318.8

Book Value ₹ 81.8

Face Value 10

52W High ₹378.9

Dividend Yield 0%

52W Low ₹ 241

Edit Ratio

DMCC Speciality Chem Research see more...

Overview Inc. Year: 1919Industry: Chemicals

The Dharamsi Morarji Chemical Company Ltd offers speciality chemicals and commodity chemicals. The Company's segments include Chemicals and Others. It offers its merchandise in numerous classes, such as base chemicals, along with Chloro Sulphonic Acid (Commercial Grade), Diethyl Ether, Oleum 23% (Commercial Grade), Oleum 65% (Commercial Grade), Sulfuric Acid (Battery Grade) and Sulfuric Anhydride (Stabilised); functional chemicals, which includes 3,3' - Diamino Diphenyl Sulfone, Benzene Sulfonamide and Benzene Sulfonic Acid; commercial intermediates, together with 3,3' - Dinitro Diphenyl Sulfone and Propargyl Chloride 98%, and life science, which includes 4,4' - Dichloro Diphenyl Sulfone, Benzene Sulfonyl Chloride, Diethyl Ether, Diethyl Sulfate, Sodium P-Chloro Benzene Sulfonate and Sodium Phenol Sulfonate. It gives procedure design, engineering bundle, procurement help and commissioning of plants for various products, inclusive of Single Superphosphate, Alumina Sulfate and Sulfamic Acid.

DMCC Speciality Chem Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

DMCC Speciality Chem Quarterly Results

#(Fig in Cr.)	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
Net Sales	73	81	102	113	105	72	95	86	77	81
Other Income	1	0	3	1	0	1	3	1	1	1
Total Income	73	82	105	114	105	73	97	87	77	81
Total Expenditure	65	70	91	99	101	71	80	75	67	73
Operating Profit	8	12	14	16	4	2	17	12	10	8
Interest	1	1	2	2	2	3	3	3	3	4
Depreciation	2	2	3	3	5	5	5	4	4	4
Exceptional Income / Expenses	0	0	0	0	0	0	0	0	0	0
Profit Before Tax	5	9	9	10	-3	-6	9	5	4	0
Provision for Tax	2	3	5	4	-0	-3	3	2	1	0
Profit After Tax	4	6	4	6	-3	-3	7	3	2	0
Adjustments	0	-0	0	0	0	0	-0	0	0	-0
Profit After Adjustments	4	6	4	6	-3	-3	7	3	2	0
Adjusted Earnings Per Share	1.5	2.6	1.5	2.5	-1.1	-1.3	2.7	1.3	1	0.1

DMCC Speciality Chem Profit & Loss

#(Fig in Cr.)	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	TTM
Net Sales	175	178	228	188	200	326	385	339
Other Income	1	1	1	6	8	6	5	6
Total Income	176	179	229	194	208	332	390	342
Total Expenditure	146	155	174	160	165	286	351	295
Operating Profit	30	24	55	34	43	47	39	47
Interest	5	4	3	2	2	5	11	13
Depreciation	4	4	5	6	7	8	18	17
Exceptional Income / Expenses	0	0	0	0	0	0	0	0
Profit Before Tax	21	16	47	26	34	34	11	18
Provision for Tax	4	3	1	-6	1	13	4	6
Profit After Tax	17	12	46	31	33	21	7	12
Adjustments	0	0	0	0	0	0	0	0
Profit After Adjustments	17	12	46	31	33	21	7	12
Adjusted Earnings Per Share	6.8	4.9	18.5	12.6	13.1	8.6	2.8	5.1

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	18%	27%	17%	0%
Operating Profit CAGR	-17%	5%	10%	0%
PAT CAGR	-67%	-39%	-10%	0%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	12%	0%	18%	42%
ROE Average	4%	12%	22%	22%
ROCE Average	7%	14%	21%	22%

DMCC Speciality Chem Balance Sheet

#(Fig in Cr.)	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Shareholder's Funds	60	73	116	145	173	194	198
Minority's Interest	0	0	0	0	0	0	0
Borrowings	16	21	16	17	19	60	68
Other Non-Current Liabilities	2	3	3	3	-21	-14	-13
Total Current Liabilities	71	60	53	47	70	127	131
Total Liabilities	149	157	188	212	241	367	384
Fixed Assets	83	88	99	102	108	174	230
Other Non-Current Assets	6	5	3	11	40	67	19
Total Current Assets	60	65	87	99	92	126	136
Total Assets	149	157	188	212	241	367	384

DMCC Speciality Chem Cash Flow

#(Fig in Cr.)	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Opening Cash & Cash Equivalents	2	4	4	4	8	4	2
Cash Flow from Operating Activities	29	18	21	27	32	51	30
Cash Flow from Investing Activities	-8	-9	-13	-17	-40	-98	-21
Cash Flow from Financing Activities	-19	-9	-8	-6	3	45	-10
Net Cash Inflow / Outflow	2	0	0	5	-4	-2	-1
Closing Cash & Cash Equivalent	4	4	4	8	4	2	2

DMCC Speciality Chem Ratios

#	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Earnings Per Share (Rs)	6.83	4.93	18.5	12.62	13.06	8.56	2.78
CEPS(Rs)	8.33	6.61	20.31	15.09	15.8	11.79	9.84
DPS(Rs)	0	0.5	0.5	0	2	1	0
Book NAV/Share(Rs)	23.99	29.18	46.43	58.09	69.44	77.64	79.49
Core EBITDA Margin(%)	15.65	12.58	23.49	14.82	17.23	12.17	8.64
EBIT Margin(%)	13.98	10.84	21.97	14.86	17.71	11.57	5.39
Pre Tax Margin(%)	11.33	8.65	20.75	13.78	16.54	10.22	2.7
PAT Margin (%)	8.99	6.8	20.27	16.77	15.83	6.39	1.76
Cash Profit Margin (%)	10.96	9.12	22.26	20.05	19.15	8.8	6.24
ROA(%)	11.44	8.04	26.74	15.73	14.39	7.02	1.85
ROE(%)	28.49	18.54	48.94	24.14	20.49	11.64	3.54
ROCE(%)	29.52	20.93	42.55	18.15	19.3	15.63	7.23
Receivable days	41.18	44	41.95	53.34	50.58	44.82	47.35
Inventory Days	31.81	37.58	36.61	51.18	57.65	43.32	44.04
Payable days	129.64	120.71	91.88	84.48	92.9	92.9	112.55
PER(x)	13.97	19.24	7.93	5.36	24.36	42.53	86.33
Price/Book(x)	3.98	3.25	3.16	1.16	4.58	4.69	3.02
Dividend Yield(%)	0	0.53	0.34	0	0.63	0.27	0
EV/Net Sales(x)	1.5	1.44	1.68	0.98	4.11	3.06	1.81
EV/Core EBITDA(x)	8.7	10.78	7.02	5.41	19.02	21.36	17.97
Net Sales Growth(%)	0	1.7	27.71	-17.54	6.65	63.03	17.91
EBIT Growth(%)	0	-26.02	155.05	-44.23	30.7	6.06	-45.21
PAT Growth(%)	0	-27.87	275.25	-31.81	3.55	-34.5	-67.52
EPS Growth(%)	0	-27.87	275.25	-31.81	3.55	-34.5	-67.52
Debt/Equity(x)	0.5	0.34	0.19	0.17	0.2	0.48	0.51
Current Ratio(x)	0.85	1.08	1.64	2.13	1.32	0.99	1.04
Quick Ratio(x)	0.61	0.73	1.16	1.53	0.79	0.66	0.63
Interest Cover(x)	5.27	4.94	18.04	13.73	15.18	8.57	2
Total Debt/Mcap(x)	0.14	0.1	0.06	0.15	0.04	0.1	0.17

DMCC Speciality Chem Shareholding Pattern

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	53.35	53.84	53.84	53.84	53.84	53.84	53.84	53.84	53.84	53.84
FII	0	0.03	0	0.06	0.1	0.05	0	0	0	0
DII	1.24	1.24	1.24	1.24	1.24	1.24	1.24	1.24	1.26	1.24
Public	45.4	44.89	44.91	44.85	44.82	44.86	44.91	44.91	44.9	44.92
Others	0	0	0	0	0	0	0	0	0	0
Total	100	100	100	100	100	100	100	100	100	100

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	1.33	1.34	1.34	1.34	1.34	1.34	1.34	1.34	1.34	1.34
FII	0	0	0	0	0	0	0	0	0	0
DII	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03
Public	1.13	1.12	1.12	1.12	1.12	1.12	1.12	1.12	1.12	1.12
Others	0	0	0	0	0	0	0	0	0	0
Total	2.49	2.49	2.49	2.49	2.49	2.49	2.49	2.49	2.49	2.49

Pros

Cons

Company has a low return on equity of 12% over the last 3 years.
Debtor days have increased from 92.9 to 112.55days.
Stock is trading at 3.9 times its book value.
The company has delivered a poor profit growth of -10% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.